17 nov. 2000 DESCRIPTION: XELODA (capecitabine) is a fluoropyrimidine carbamate ... Mechanism of Action: Both normal and tumor cells metabolize 5-FU to ...
lbl
1 mai 2021 MECHANISM OF ACTION: ... The mechanism of capecitabine-related cardiotoxicity is not known.24 Risk factors ... XELODA® product monograph.
Capecitabine monograph
La capécitabine (Xeloda®) est un antinéoplasique. au 5-FU administré par voie veineuse étant donné son efficacité et son mode d'administration par.
Mode d'action . XELODA (capécitabine) est indiqué dans le traitement adjuvant du cancer du côlon de stade III (stade C selon la classification de Dukes) ...
Xeloda PM F
Xeloda (capecitabine). An overview of Xeloda and why it is authorised in the EU. What is Xeloda and what is it used for? Xeloda is a cancer medicine that is
xeloda epar summary public en
Data from cultured human cancer cell lines indicate that capecitabine becomes cytotoxic only after conversion to 5-FU. Studies on the mechanism of action of 5-
xeloda epar scientific discussion en
A - Drug Name capecitabine. COMMON TRADE NAME(S): Xeloda® back to top. B - Mechanism of Action and Pharmacokinetics. Capecitabine is an antimetabolite
capecitabine ?download=
4 avr. 2022 Mechanism of Action . ... XELODA (capecitabine) is indicated for the adjuvant treatment of patients with stage III.
Xeloda PM E
XELODA (capecitabine) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: 12.1 Mechanism of Action. 12.3 Pharma cokinetics.
s lbl
Xeloda 500 mg comprimés pelliculés. Chaque comprimé pelliculé contient 150 mg de capécitabine. Xeloda 500 mg ... 4.2 Posologie et mode d'administration.
xeloda epar product information fr